葛根素对腹膜透析液诱导人腹膜间皮细胞分泌TGF-β1的影响

目的:了解葛根素对腹膜透析液干预下的体外培养人腹膜间皮细胞分泌转化生长因子β1(TGF-β1)的影响.方法:体外培养的人腹膜间皮细胞,分对照组、PDS组、A组(葛根素终浓度为50μg/mL)、B组(葛根素终浓度为100μg/mL)、C组(葛根素终浓度为200μg/mL)五组观察.检测各组上清液中TGF-β1的含量并比较.结果:腹膜间皮细胞在PDS干预下,TGF-β1分泌显著增加,添加葛根素再干预的A、B、C组TGF-β1分泌与PDS组比较有显著下降.结论:葛根素对腹膜透析液诱导的腹膜间皮细胞分泌致纤维化因子TGF-β1具有抑制作用.     

6种晋产野生葛根中葛根素、大豆苷和总黄酮含量比较

采用高效液相色谱法对山西省5地6处野生葛根中主要有效成分葛根素、大豆苷及总黄酮含量进行了分析,并对HPLC法的测定条件(流动相和洗脱程序)进行了优化。结果表明,6种晋产野生葛根中主要有效成分含量差异显著,葛根素的含量为1.46%~4.48%,大豆苷的含量为0.11%~0.62%,总黄酮的含量为11.19%~26.14%。葛根素、总黄酮含量与纬度高低呈正相关。晋南绛县么里镇小北山与夏县泗交镇太宽河自然保护区的野生葛根中葛根素含量低于《中国药典》规定的2.4%,而晋北灵丘县的野生葛根中葛根素含量则高达4.48%。     

湘西产野葛不同部位中总黄酮及葛根素的含量测定

本文采用UV、TLC法对野葛不同部位总黄酮及葛根素的含量进行了测定,结果野葛块根比茎叶中黄酮和葛根素含量都高,其黄酮含量为4.12%,是叶的4.24倍;葛根素含量为2.43%,是叶的243倍。     

腹透液相关浓度葡萄糖对人腹膜间皮细胞端粒长度的影响及葛根素的拮抗作用

目的:研究腹透液相关浓度葡萄糖(1.5%、2.5%)对人腹膜间皮细胞端粒长度的影响及葛根素的拮抗作用.方法:人腹膜间皮细胞在含糖(1.5%、2.5%)、含糖含葛根素(葛根素终浓度为100μg/ml)的无血清培养基培养24h后,收集细胞,提取DNA,采用Southerm杂交测定细胞端粒长度.结果:经含糖1.5%和2.5%培养基培养24h后腹膜间皮细胞大多出现肥大.高浓度葡萄糖组细胞端粒长度缩短,2.5%组和1.5%组无显著差别(P>0.05).葛根素加入后含糖组腹膜间皮细胞端粒长度延长(P<0.05).结论:高糖可使间皮细胞端粒缩短,且可能与高糖作用下细胞肥大有关,葛根素可拮抗高糖对间皮细胞端粒长度的影响.     

太白山野葛根中异黄酮和葛根素含量随季节的变化

为了考察太白山野葛根中异黄酮及葛根素含量随季节的变化。采集一年12个月份的野葛根,采用紫外分光光度法测定其中异黄酮含量;以7高效薄层色谱扫描法测定野葛根中游离葛根素及总葛根素含量。结果表明：三月份异黄酮含量最高,为18.53%;四月份游离葛根素及总葛根素含量最高,分别为7.45%和8.93%。对不同季节太白山野葛根中异黄酮、游离葛根素及总葛根素进行定量分析,为这一野生资源的合理采收和开发利用提供了实验依据。     

HPLC同时测定妇科调经片中芍药苷与阿魏酸的含量

目的:建立同时测定妇科调经片中芍药苷与阿魏酸含量的高效液相色谱方法。方法:采用Agilent C18柱(4.6×250mm 5μm)甲醇-0.1%磷酸水溶液(25:75)为流动相洗脱,流速为1.0mL/min,检测波长为多波长检测。结果:芍药苷与阿魏酸分别在0.0181μg~0.1810μg、0.0106μg~0.1060μg范围内线性关系良好,2种成分平均回收率均符合含量测定要求。结论:本法简单易行,结果准确可靠,可有效地用于妇科调经片的质量控制。     

融粘帚霉对葛根素的生物转化研究

采用融粘帚霉AS3.3987对葛根素进行微生物转化,生成的主要产物经分析鉴定是3′-羟基葛根素.采用高效液相色谱方法,以XDB-C18为色谱柱,甲醇:水(27∶73)为流动相,检测波长为254 nm,测得在160 r/min、30 ℃的转化条件下,底物加量为400 μg/mL,转化时间为36 h时,3′-羟基葛根素得率...     

高效液相色谱法测定川射干鸢尾苷元磺酸钠及其制剂泰克吉宁注射液含量和有关物质

建立高效液相色谱法测定鸢尾苷元磺酸钠(4′,5,7-三羟基-6-甲氧基异黄酮-5′-磺酸钠)及其制剂泰克吉宁注射液的含量及有关物质。采用C18色谱柱(150×4.6mm,5μm),流动相为甲醇-5%醋酸水(80:20),流速为1.0mL/min,检测波长为263nm。鸢尾苷元磺酸钠在11～100μg/mL范围内线性关系良好,回归方程Y=43.3609X-1.5973(r=0.99998),平均回收率为99.77%(n=9)。最低检测限为0.052μg/mL,与有关物质分离良好。本法快速、简便、准确,专属性强。     

丹葛酚酮胶囊HPLC指纹图谱及9种有效成分的含量测定

建立丹葛酚酮胶囊的HPLC指纹图谱,并同时测定其中9种有效成分的含量,为其质量评价提供依据。采用Eclipse XDB-C_(18)色谱柱(4.6 mm×250 mm,5μm),以0.05%甲酸-乙腈为流动相梯度洗脱,流速1.0 mL/min,检测波长280 nm,柱温30℃,进样量10μL,建立了丹葛酚酮胶囊的HPLC指纹图谱。10批丹葛酚酮胶囊指纹图谱中有28个共有峰,相似度均大于0.99,经与对照品比对确认了16个成分,对葛根素、3′-羟基葛根素、3′-甲氧基葛根素、葛根素芹菜糖苷、大豆苷、丹酚酸B、隐丹参酮、丹参酮Ⅰ、丹参酮Ⅱ_A 9种主要成分进行了定量分析,线性、精密度、稳定性、重复性和加样回收率均符合定量要求,所建立的方法简便、稳定、可靠,指纹图谱结合多指标成分的含量可有效控制产品的质量。     

酸水解法从葛根中提取分离葛根素和大豆苷元

本文报道了葛根黄酮的提取精制方法,以６０％乙醇为溶剂,６０℃温浸６ｈ的优化工艺条件下,采用逆流萃取法从葛根中提取葛根黄酮,其收得率为１９．２８％,含量５１．０５％。葛根黄酮提取物采用５％盐酸水解４ｈ,酸水解液用乙酸乙酯萃取放置析出葛根素,乙酸乙酯相经水洗、浓缩和重结晶可得大豆苷元。采用酸水解法可以将葛根黄酮中的葛根素及大豆苷元衍生物水解成葛根素和大豆苷元,有利于葛根素、大豆苷元的分离及产率的提高;该方法从葛根中提取分离葛根素和大豆苷元具有操作简便、产品纯度和产率高、成本低的特点。葛根素和大豆苷元产率分别为１．３６％和０．４５％,纯度为９８．３２％和９１．２５％。     

葛根素对人非小细胞肺癌A549细胞凋亡的作用

目的：观察葛根素对人非小细胞肺癌A549细胞生长的抑制作用及其机制。方法：体外培养人非小细胞肺癌细胞（A549）,不同浓度（60 μg/ml,120 μg/ml,240 μg/ml）葛根素处理24 h后;采用CCK-8法观察葛根素对细胞的增值抑制作用;吖啶橙（AO）/溴化乙锭（EB）双染法及AnnexinⅤ-PI双染流式细胞术检测药物作用前后A549细胞的形态学变化及凋亡状况;Western blot法检测Apelin/APJ蛋白水平的变化。结果：CCK-8法检测结果说明葛根素能抑制A549细胞的增值,具有浓度和时间依赖关系;流式细胞术进一步证实葛根素具有诱导细胞凋亡的作用,与A549细胞组比较,葛根素各处理组Apelin/APJ蛋白水平均有不同程度下调。结论：葛根素可能通过调节Apelin/APJ蛋白的表达诱导A549细胞凋亡。     

葛根素配位特性研究

本文运用配位化学的基本原理,采用pH电位滴定法,对葛根素的配位特性进行研究。结果表明在碱性条件下,葛根素结构易发生改变。在25℃和37℃,葛根素能和铜离子、锌离子、铁离子、铝离子、钙离子形成配合物。计算得出葛根素与Cu2 、Ca2 、Zn2 、Al3 、Fe2 的络合稳定常数lgK分别为3.28、2.16和1.12、2.85和1.72、2.78和1.63、2.94和1.87。     

The Study on the Entrapment Efficiency and In Vitro Release of Puerarin Submicron Emulsion

The entrapment efficiency (EE) and release in vitro are very important physicochemical characteristics of puerarin submicron emulsion (SME). In this paper, the performance of ultrafiltration (UF), ultracentrifugation (UC), and microdialysis (MD) for determining the EE of SME were evaluated, respectively. The release study in vitro of puerarin from SME was studied by using MD and pressure UF technology. The EE of SME was 86.5%, 72.8%, and 55.8% as determined by MD, UF, and UC, respectively. MD was not suitable for EE measurements of puerarin submicron oil droplet, which could only determine the total EE of submicron oil droplet and liposomes micelles, but it could be applied to determine the amount of free drug in SMEs. Although UC was the fastest and simplest to use, its results were the least reliable. UF was still the relatively accurate method for EE determination of puerarin SME. The release of puerarin SME could be evaluated by using MD and pressure UF, but MD seemed to be more suitable for the release study of puerarin emulsion. The drug release from puerarin SME at three drug concentrations was initially rapid, but reached a plateau value within 30 min. Drug release of puerarin from the SME occurred via burst release.     

葛根素对正常产后小鼠泌乳作用的影响

摘要 目的：探究葛根素对产后正常小鼠泌乳作用的影响及其机制,并初步探究葛根素对产后正常小鼠的安全性。方法：将雌、雄KM小鼠以3:1比例合笼配种,得到孕鼠饲养至分娩。分娩后的小鼠随机分为正常对照组、葛根素低剂量（18 mg?kg^-1）、高剂量组（72 mg?kg^-1）,每组8只。从产后第3 d起,每天灌胃一次,共10 d。观察小鼠每日泌乳量变化,ELISA法检测血清中催乳素（PRL）、孕酮（P4）、雌二醇（E₂）含量,HE染色观察乳腺、肝、肾、子宫、卵巢组织病理学形态,Western Blot法检测乳腺组织中催乳素受体（PRLR）、酪氨酸激酶 2（JAK2）和信号传导与激活因子5a（STAT5a）的表达。结果：与正常对照组相比,从给药的第6天起,葛根素低剂量组的泌乳量显著升高（P＜0.05）;葛根素低、高剂量组均可见乳腺小叶内腺泡明显变大,分泌物明显增多,且低剂量组更为明显;葛根素低、高剂量组血清PRL水平明显升高（P＜0.01或P＜0.05）;葛根素低剂量组PRLR的蛋白表达明显增加（P＜0.01）,而葛根素高剂量组PRLR、JAK2的蛋白表达明显降低（P＜0.01）。葛根素低剂量组PRLR、JAK2、STAT5a的蛋白表达明显高于葛根素高剂量组（P＜0.01或P＜0.05）。结论：葛根素低剂量对产后正常小鼠有一定促进泌乳作用,高剂量时对泌乳作用不明显。葛根素低、高剂量均未对产后正常小鼠的肝、肾、卵巢和子宫产生明显的病理学改变。     

葛根素对大鼠心室肌细胞动作电位的影响

目的:从电生理角度探讨葛根素抗心律失常的可能机制。方法:采用膜片钳技术记录大鼠心室肌细胞动作电位(AP)、转染的人胚胎肾细胞缓慢延迟整流钾电流(IKs),观察加药前、后葛根素对AP和IKs的影响。结果:0.01、0.1、1 mmol/L葛根素可浓度依赖性地延长动作电位时程,分别使APD50从(71.8±11.8)ms延长至(86.9±10.7)ms、(100.5±14.1)ms和(123.6±25.4)ms;使APD90从(164.6±21.4)ms延长至(188.3±11.5)ms、(221.6±25.7)ms和(278.7±38.2)ms(n=6,均P0.05),而对RMP、APA和APD20无显著影响。此外,0.01、0.1、1 mmol/L葛根素对IKs抑制率分别为(17.8±2.5)%、(40.4±1.9)%和(60.9±3.2)%(n=6,均P0.05)。结论:葛根素可能通过抑制IKs来延长动作电位时程,发挥抗心律失常作用。     

葛根素对体外培养的人老年女性骨质疏松症成骨细胞分化的初步研究

目的:观察葛根素对体外培养老年女性骨质疏松症骨折患者体外分离培养的成骨细胞分化的影响。方法:采集老年女性骨质疏松症股骨颈骨折行人工股骨头置换术中取下的股骨颈松质骨,采用骨组织块法原代培养成骨细胞。观察不同浓度(0、0.01、0.1、1μmol/L)葛根素对成骨细胞表达碱性磷酸酶(alkaline phosphatase,ALP)、骨钙素(osteocalcin,OC)的影响,并比较各组成骨细胞钙化能力的大小。结果:0.01~1.00μmol/L的葛根素随着浓度增加,成骨细胞表达ALP、OC活性呈增强趋势,各浓度组两两比较差异均有统计学意义(P0.05);随葛根素浓度增高,成骨细胞钙化结节数量也明显增加,组间比较差异有统计学意义(P0.05)。结论:葛根素呈浓度依赖性促进成骨细胞表达ALP、OC并能提高成骨细胞的钙化能力。     

葛根素减轻部分由过氧亚硝基阴离子导致的糖尿病大鼠晶状体上皮细胞凋亡

本研究观察葛根素是否减轻部分由过氧亚硝基阴离子（peroxynitrite,ONOO^-）导致的糖尿病大鼠晶状体上皮细胞（lens epithelium cell,LEC）凋亡。采用大鼠腹腔注射链脲佐菌素（streptozotocin,STZ）的方法建立糖尿病动物模型。36只大鼠作为对照组,腹腔注射生理盐水;其他72只大鼠腹腔注射STZ（45mg/kg）后分为STZ组和STZ＋葛根素组,每组36只。STZ注射3d后,STZ＋葛根素组大鼠每天腹腔注射葛根素（140mg／kg）。于实验开始后第20、40和60天用裂隙灯检查晶状体的形态学变化后处死动物。用流式细胞仪检测LEC凋亡,用免疫组化方法检测晶状体中ONOO^-的标志物——硝基酪氨酸（nitrotyrosine,NT）的表达,用基因芯片分析技术检测LEC凋亡相关基因iNOS等的表达。结果发现,对照组大鼠晶状体均透明,各项指标基本正常;STZ组大鼠第20天时即出现晶状体混浊,40-60d期间混浊不断加重;STZ＋葛根素组大鼠20-40d时晶状体混浊呈加重趋势,但40-60d以后明显减轻。对照组LEC轻度凋亡,而STZ组凋亡细胞呈持续性增长,STZ＋葛根素组大鼠20-40d时细胞凋亡呈增长趋势,但40-60d以后明显下降。对照组大鼠晶状体NT未见明显表达;STZ组大鼠NT表达明显加强;STZ＋葛根素组大鼠20-40d时NT表达呈增长趋势,但40-60d以后明显下降。对照组凋亡相关基因未见明显变化,STZ组凋亡相关基因iNOS表达明显上调。其他凋亡相关基因如BCL-2、SOD表达明显下调,但NF-κB和TNFR1-FADD-caspase信号转导途径明显上调;STZ＋葛根素组凋亡相关基因表达则呈相反改变。上述结果表明,在糖尿病大鼠晶状体中有ONOO^-的标志物NT表达,证明糖尿病大鼠LEC凋亡部分由ONOO^-诱导,这可能是氧化损伤导致白内障形成的新途径。葛根素能够部分逆转ONOO^-对LEC的致凋亡作用,提示葛根素可能是治疗糖尿病性白内障的有效药物,其治疗机制可能与葛根素直接抑制凋亡和对抗ONOO^-对糖尿病大鼠LEC的损伤有关。     

Determination of puerarin in biological samples and its application to a pharmacokinetic study by flow‐injection chemiluminescence

A simple and sensitive flow injection–chemiluminescence (FI–CL) method has been developed for the determination of puerarin, based on the fact that puerarin can greatly inhibit CL of the luminol–H₂O₂–haemoglobin system. The inhibition of CL intensity was linear to the logarithm of the concentration of puerarin in the range 0.08–10.0 μg/mL (r² = 0.9912). The limit of detection was 0.05 μg/mL (3σ) and the relative standard deviation (RSD) for 1.0 μg/mL (n = 11) of puerarin solution was 1.4%. Coupled with solid‐phase extraction (SPE) as the sample pretreatment, the determination of puerarin in biological samples and a preliminary pharmocokinetic study of puerarin in rats were performed. The recoveries for plasma and urine at three different concentrations were 89.2–110.0% and 91.4–104.8%, respectively. The pharmacokinetics of puerarin in plasma of rat coincides with the two‐compartment open model. The T_1/2α, T_1/2β, CL/F, V_Z/F, AUC_{(0 – t)}, MRT_{(0 – ∞)}, T_max and C_max were 0.77 ± 0.21 h, 7.55 ± 2.64 h, 2.43 ± 1.02 L/kg/h, 11.40 ± 3.45 L/kg, 56.67 ± 10.65 mg/h/L, 5.04 ± 2.78 h, 1.00 ± 0.35 h and 19.70 ± 4.67 μg/mL, respectively. Copyright © 2011 John Wiley & Sons, Ltd.     

Effects of Puerarin on Lipid Accumulation and Metabolism in High-Fat Diet-Fed Mice

In order to investigate the mechanisms by which puerarin from kudzu root extract regulates lipid metabolism, fifty mice were randomly assigned to five groups: normal diet, high-fat diet (HFD), and HFD containing 0.2%, 0.4% or 0.8% puerarin for 12 weeks. Body weight, intraperitioneal adipose tissue (IPAT) weight, serum biochemical parameters, and hepatic and feces lipids were measured. Activity and mRNA and protein expressions of hepatic lipid metabolism-related enzymes were analyzed. Compared with HFD, 0.4% and 0.8% puerarin significantly decreased body and IPAT weight. There was a significant decrease in the serum and hepatic concentrations of total cholesterol, triglycerides and leptin in mice fed the 0.4% and 0.8% puerarin diets compared with HFD. Fatty acid synthase activity was suppressed in mice fed the 0.4% and 0.8% puerarin diets, while the activities of AMP-activated protein kinase (AMPK), carnitine acyltransferase (CAT) and hormone-sensitive lipase (HSL) were increased. mRNA expression of peroxisome proliferator-activated receptor γ 2 (PPARγ 2) was down-regulated in liver of mice fed the 0.8% diet compared with HFD, while mRNA expression of CAT and HSL was considerably up-regulated by 0.4% and 0.8% puerarin diets. The protein expression of PPARγ2 in liver was decreased and those of p-AMPK, HSL and p-HSL were increased in mice fed 0.4% and 0.8% puerarin diets. These results suggest that > 0.4% puerarin influenced the activity, mRNA and protein levels of hepatic lipid metabolism-related enzymes, decreasing serum and liver lipids, body weight gain and fat accumulation. Puerarin might be beneficial to prevent lifestyle-related diseases.     

Using PG-Liposome-Based System to Enhance Puerarin Liver-Targeted Therapy for Alcohol-Induced Liver Disease

A critical issue for alcohol-induced liver disease (ALD) therapeutics is the lack of a highly efficient delivery system. In this study, a Puerarin-propylene glycol-liposome system was prepared for the purpose of targeting puerarin, an isoflavon, to the liver. Transmission electron microscope (TEM) results showed the liposomes to be spherical in shape with an average diameter of 182 nm with a polydispersity index of 0.239. The zeta potential of the particles was about ?30 mV. The entrapment efficiency of puerarin was above 90%. MTT-based assay in HpeG2 cells showed no significant cytotoxicity in the presence of up to 25% concentration of the system containing 3% puerarin. In vivo performance of this system was studied in mice. Pharmacokinetics and distribution of puerarin-PG-liposome system was studied relative to puerarin solution at the same dose levels. The results show that puerarin-PG-liposome prolonged drug retention time and decreased elimination of puerarin in mice (AUC of liposome system and solution was 9.5 and 4.0 mg h L^?1, respectively). Furthermore, propylene glycol (PG)-liposome system enhanced puerarin distribution into liver and spleen, while decreasing puerarin distribution in other tissues. Overall, the puerarin-PG-liposome system showed enhanced therapeutic effect in mice with ALD.